Mannose-Equipped Nanogels Disrupt Pathogen Shields

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Mannose residues on pathogens form clusters that self-interact and create a 'shield' of structured water, making it difficult for mannose-binding lectins to recognize and target these pathogens, thereby hindering the immune system's ability to effectively respond to infections.

Innovation Solution

Delivering mannose-equipped nanogels that disrupt mannose self-interactions and water structuring on pathogen surfaces, allowing mannose receptors on immune cells to more easily recognize pathogens, which includes mannose-coated or filled nanogels that release mannobiose cargo to interfere with mannose clusters and enhance lectin recognition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If mannose residues are present in clusters on pathogen surfaces, then the pathogen can resist lectin binding and immune recognition, but this self-interaction creates a shield that prevents effective immune response

Engineering Contradiction:
Improveimmune recognition capabilityVSAvoidmannose self-interaction shield
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces mannobiose as an intermediary substance that binds to mannose clusters on pathogen surfaces. This intermediary molecule disrupts the self-interaction shield formed by mannose residues, making the pathogen surface more accessible to lectins and immune receptors. The mannobiose acts as a mediator that translates the harmful mannose clustering into a beneficial state for immune recognition.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical and physical parameters of the mannose surface by introducing mannobiose, which alters the self-interaction properties of mannose residues. This parameter change disrupts the structured water moat and mannose-mannose bonding, transforming the surface from a protective shield to an accessible target for immune recognition.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If concentrated lectins are introduced to bind mannose-containing viruses, then immune recognition is enhanced, but the mannose clusters self-latch and prevent lectin access

Engineering Contradiction:
Improvelectin binding efficiencyVSAvoidmannose cluster self-latching
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Mannobiose serves as a mediator that interferes with the self-latching mechanism of mannose clusters. By binding to the mannose residues, mannobiose prevents the clusters from forming protective self-latched structures, thereby enabling lectins to access and bind to mannose-containing pathogens effectively.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies preliminary action by introducing mannobiose before lectin binding occurs. This preliminary disruption of mannose self-interactions prepares the pathogen surface to be more receptive to lectin binding, effectively preventing the self-latching barrier from forming in the first place.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If free mannose is delivered to disrupt mannose self-interactions, then lectin recognition is enhanced, but the delivery mechanism must overcome the protective water structuring moat

Engineering Contradiction:
Improvelectin recognition enhancementVSAvoidstructured water moat
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Mannobiose acts as an intermediary that penetrates or disrupts the structured water moat surrounding mannose clusters. By introducing mannobiose into this protected environment, the patent enables disruption of mannose self-interactions without requiring direct delivery of lectins through the water barrier.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical chemistry parameters of the water-mannose interface by introducing mannobiose, which alters the structured water moat's properties. This parameter change allows mannose self-interactions to be disrupted while maintaining effective delivery mechanisms.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the immune system's ability to recognize and destroy pathogens by making mannose residues on pathogens more accessible, thereby preventing or reducing infections caused by a broad spectrum of diseases, including Ebola, Marburg, SARS, Dengue, and HIV, and potentially cancer cells.

Implementation Method 1

Mannose residues on pathogens form clusters that self-interact

Methodology Applied
Scientific EffectHydrogen bonding:

Implementation Method 2

mannose residues to bind to one another

Methodology Applied
Scientific EffectVan der Waals force: Van der Waals Force

Implementation Method 3

Mannose clusters also appear to build a 'moat' of structured water over them interfering with access to the mannose residues

Methodology Applied
Scientific EffectWater structuring:

Implementation Method 4

Free forms of mannobiose interfere with ordered packing between anchored mannose residues, disrupting both self-stickiness and water-structuring

Methodology Applied
Scientific EffectDisruption of ordered packing:

Data Source

PatentUS11672822B2Preventative mannose therapy and treatment of viral infections using mannose-containing compositions
Publication Date: 2023.06.13 HOWARD UNIVERSITY
  • US11672822B2 patent drawing

AI summary

Methods and compositions are provided for preventing and/or treating infection by disrupting interactions at or near the surface of mannosylated pathogens or other pathogens exhibiting carbohydrate-carbohydrate self-interaction, thus enhancing the immune system's ability to recognize and destroy such pathogens. In some forms, carrier molecules are provided to delivering polymers or other molecules capable of disrupting intra-cellular interaction and/or self-interaction of surface markers on cells.